Trials / Unknown
UnknownNCT03394469
Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This project aims first to determine the prevalence of sarcopenia in a population of obese people of extended age group (18-70 years). In a second step, the factors determining and / or predisposing to sarcopenic obesity will be identified as well as plasmatic and urinary biomarkers specific to this phenotype.
Detailed description
Collection of clinical and paraclinical data (biological and anthropometric) for evaluation of sarcopenic obesity in obese patients. Biological collection to identify plasma, serum, genetic, urinary and faecal biomarkers associated with sarcopenic obesity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | collection | Blood, urinary and faecal samples |
Timeline
- Start date
- 2018-06-04
- Primary completion
- 2020-06-06
- Completion
- 2020-06-06
- First posted
- 2018-01-09
- Last updated
- 2019-02-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03394469. Inclusion in this directory is not an endorsement.